It is reported that next year China will impose a tentative tariff rate for imports of more than 780 kinds of imported goods below the MFN tariff rate, in which special formula milk powder tariff for infants and young children is 5%, which is significantly lower than 15% of MFN treatment, which is half of the current tax rate. The import tax rate for retail packaged foods for infants and young children is reduced from 15% to 5%, and soy sauce is reduced from 28% to 15%. The pace of tax reduction for pacemakers, stents, and other medical devices that are subject to tens of thousands of medical devices is expected by doctors and patients. The industry believes that the market share of imported devices will continue to expand, or the prices of domestic devices will be forced to lower prices.

It is reported that cardiac pacemakers, stents and other medical devices have also been included in the list of tariff reductions. “The proportion of hospitals used in the top three hospitals is still superior to imported equipment,” said Associate Professor Chen Yantao, of the Department of Orthopaedics at Sun Yat Sen Memorial Hospital, Sun Yat-Sen University.

"The price difference between imported and domestic equipment is about 40%. In fact, the gap between the two is not so great. There is indeed room for price cuts for imported goods." A professor of surgery revealed that if the tax rate is reduced, There will be no impact on domestic pacemakers and vascular stents. “Because of the price aside, doctors and patients will still consider importing equipment first. It is believed that lowering tariffs will continue to increase the use of imported equipment in terminals. It is very likely that domestic equipment will be forced to lower prices.” He believes that this is a major positive news for doctors and patients.

It is understood that at present, the number of implanted pacemakers in China accounts for only 10% of the total number of implanted patients. However, the excessively high prices lead to patients' "unable to use" is the biggest reason for the extremely low implantation rate, as the world's population In the first country, sales of pacemakers in China were only 1/14th of global sales in 2011.

At present, the import of single-chamber pacemakers is about 25,000 yuan to install, the import of dual-chamber pacemakers is about 45,000 yuan, and each of the more advanced functions requires 60,000 to 70,000 yuan or even 100,000 to 200,000 yuan. .